Exhale-DxTM:一种非侵入性,实时呼吸分析系统,使用深度学习进行喘诊断
Hanya Ahmed1, Jona Angelica Flavier1, Victor Higgs1
1Department of Research and Development, Applied Nanodetectors Ltd., London N5 2EF, United Kingdom.
Journal of biological methods
|September 12, 2025
概括
一个新的呼吸测试平台Exhale-DxTM和一个人工智能模型ADENA使用挥发性有机化合物准确诊断喘. 这为呼吸系统健康提供了早期检测和干预,改善了患者的治疗结果.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 生物标志物发现发现
- 医疗保健中的人工智能
背景情况:
- 喘影响着全球数以百万计的患者,带来了诊断挑战和严重的医疗负担,特别是在英国.
- 严重的喘占支出的50%以上,往往导致可预防的紧急住院和死亡.
- 目前的诊断方法依赖于临床病史,导致高达90%可预防的喘死亡的延迟和错误诊断.
研究的目的:
- 推出Exhale-DxTM,这是一个用于非侵入性喘诊断和监测的临床呼吸测试.
- 开发一个先进的深度神经网络 (ADENA),以提高使用呼吸生物标志物的喘诊断精度.
- 为了能够提前三天提前发现恶化的情况,以便及时介入.
主要方法:
- 呼出-DxTM捕获呼出的气息中的挥发性有机化合物 (VOC) 作为实时肺功能标志物.
- 喘诊断增强神经架构 (ADENA) 是使用VOC数据和肺功能参数开发的.
- 亚德纳集成波波形和临床喘控制得分进行综合分析.
主要成果:
- 阿德纳显示出高诊断性能,准确率为98.7%,F1得分为0.98.
- 该模型实现了0.065的低平均平方误差,表明了精确的诊断能力.
- 分解分析证实ADENA能够区分喘和非喘生理特征.
结论:
- 挥发性有机化合物 (VOC) 分析与深度神经网络相结合,可以准确识别喘特征.
- 这种方法对早期的非侵入性呼吸系统健康诊断具有重大潜力.
- Exhale-DxTM平台和ADENA模型在喘管理和患者护理方面提供了有前途的进步.
更多相关视频
08:23Real-time Breath Analysis by Using Secondary Nanoelectrospray Ionization Coupled to High Resolution Mass Spectrometry
Published on: March 9, 2018
9.3K
06:22Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections
Published on: September 19, 2025
435
相关概念视频
Assessment of Ventilation II: Respiratory Depth and Rhythm
2.4K
Respiratory Depth
Respiratory depth measures the volume of air inhaled or exhaled during a breath. It can vary from shallow to deep and typically remains consistent when a person is at rest or asleep. Occasionally, individuals will automatically inhale deeply, known as sighing, which inflates the lungs with more air than normal breathing.
To assess respiratory depth, observe the degree of chest excursion or movement:
Respiratory depth measures the volume of air inhaled or exhaled during a breath. It can vary from shallow to deep and typically remains consistent when a person is at rest or asleep. Occasionally, individuals will automatically inhale deeply, known as sighing, which inflates the lungs with more air than normal breathing.
To assess respiratory depth, observe the degree of chest excursion or movement:
2.4K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
